CLOs on the Move

Genetics Squared

www.genetics2.com

 
Genetics Squared is a prognostics company focused on developing gene-based molecular assays for the prediction of cancer recurrence and proprietary point-of-care equipment for the evaluation and management of cardiovascular disease.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Avery Manor

Avery Manor is a Needham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OncoCell MDx

OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary technologies created at Harvard Medical School. In particular, we have developed a noninvasive blood-based immunogenomic assays that will aid the physician to better understand the underlying pathology. The first product is for assessing the severity of prostate cancer. Other oncology indications as well as non-oncology indications are part of our pipeline. The assay is based on examining specific transcription levels between phagocytic and non-phagocytic cells. This proprietary technology and algorithm has allowed us to not only detect disease but to also, and more importantly, guide the physician as to the grade and aggressiveness of the disease. Our mission is to provide clinicians with quantifiable results that allows professionals to make timely and much more directed medical decisions.

Memphis Center for Independent Living

Memphis Center for Independent Living is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Betsy Johnson Regional Hospital

Betsy Johnson Regional Hospital is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Betsy Johnson Regional Hospital is based in Dunn, NC. You can find more information on Betsy Johnson Regional Hospital at www.bjrh.org

Global Multi Media Pro Care

Global Multi Media Pro Care is a Joplin, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.